Skip to content

Inhibition of Dental Plaque Regrowth by an Ethanol-Free 0,2% Chlorhexidine Mouth Rinsing Solution

Inhibition of Dental Plaque Regrowth by an Ethanol-Free 0,2% Chlorhexidine Mouth Rinsing Solution

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2006-005953-31-DE
Enrollment
42
Registered
2007-08-15
Start date
2007-05-03
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The purpose of this study is to examine the inhibitory effect of an ethanol-free 0,2% chlorhexidine digluconate (CHX) mouthrinse on the bacterial plaque growth after professional tooth cleaning in the absence of domestic oral hygiene in healthy volunteers.

Interventions

Product Name: Test Solution 1 Product Code: Test Solution 1 Pharmaceutical Form: Oromucosal solution Pharmaceutical form of the placebo: Oromucosal solution Route of administration of the placebo: Oro

Sponsors

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: – healthy volunteers – minimum number of 20 natural teeth in the mouth – age = 20 = 50 years – regular dental care at home – healthy mucosa with the exception of gingivitis simplex or periodontal recessions Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Exclusion Criteria: – systemic diseases – participation in a clinical trial within the last 30 days or subject has already participated in this clinical study – regular use of drugs interfering with plaque formation or the generation of gingival inflammations (4 weeks before and during recruitment) o antibiotics acting locally in the mouth or systemically o steroidal and non-steroidal antiphlogistics o drugs which influence salivation (e.g. antihistaminics, anticholinergics, drugs against hypertension, psychotropics) – pregnancy or lactation – necessity of antibiotic protection prior to dental treatment interventions – current orthodontic therapy or extended restorations – known hypersensitivity to ingredients of the study medication – all types of known allergies – scheduled surgical intervention or hospitalization within the next 6 weeks – open wounds and ulcers inside the oral cavity – superficial, non-bleeding exfoliation of the oral mucosa or other acute local diseases of the oral mucosa (exception: gingivitis simplex) – GI>2 – present or previous alcoholism

Design outcomes

Primary

MeasureTime frame
Main Objective: Evaluation of the extent of 4-day plaque regrowth after professional tooth cleaning in the absence of personal oral hygiene according to the criteria of the Quigley-Hein plaque index (QHI) with the modification of Turesky et al. 1972. ;Secondary Objective: Evaluation of the progress of gingival inflammation according to the criteria of the Gingival Index (GI) of Löe and Silness (Löe and Silness 1963). ;Primary end point(s): The difference of effects of ethanol-free CHX mouthrinse solution (= test solution 1) vs. placebo will be analysed by applying a one-sided t-test for dependent samples on the pre-post-differences of QH Index as the primary endpoint.

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026